Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.65
+0.13 (1.99%)
At close: Jun 12, 2026, 4:00 PM EDT
6.78
+0.13 (1.95%)
After-hours: Jun 12, 2026, 5:15 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $697.52 million as of June 12, 2026. Its market cap has increased by 2,806.33% in one year.
Market Cap
697.52M
Enterprise Value
463.56M
1-Year Change
2,806.33%
Ranking
Category
Stock Price
$6.65
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $697.52M, an increase of 1,132.37%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 697.52M | 96.93% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 736.78M |
| Geron | 731.33M |
| Avalo Therapeutics | 718.57M |
| Replimune Group | 711.78M |
| Solid Biosciences | 710.81M |
| CorMedix | 702.93M |
| Aura Biosciences | 684.96M |
| Oculis Holding AG | 664.27M |